SCHEMBL7988962

SCHEMBL7988962

Cc1cccc(Cn2cnc3[nH]c(-c4cccc(F)c4)nc(=O)c32)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.44
GRIN2B Q13224 2/20 0.44
HPGD P15428 3/20 0.42
POLB P06746 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
P2RX7 Q99572 2/20 0.42
ALDH1A1 P00352 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
TSHR P16473 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ACP1 P24666 1/20 0.40
MET P08581 1/20 0.39
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991676 0.93 ACP1 (0.43) GRIN1GRIN2BP2RX7ACP1PARN
SCHEMBL7974471 0.91 ACP1 (0.43) GRIN1GRIN2BHPGDPOLBMEN1
SCHEMBL7988570 0.91 HPGD (0.47) GRIN1GRIN2BHPGDPOLBMEN1
SCHEMBL7974270 0.90 ALDH1A1 (0.46) HPGDALDH1A1CYP11B1CYP11B2TSHR
SCHEMBL7987255 0.90 PARN (0.48) GRIN1GRIN2BHPGDP2RX7ALDH1A1
SCHEMBL7991561 0.89 HPGD (0.43) HPGDMEN1KMT2AP2RX7ALDH1A1
SCHEMBL7975243 0.88 HTT (0.44) GRIN1GRIN2BHPGDPOLBP2RX7
SCHEMBL7987312 0.88 GRIN1 (0.48) GRIN1GRIN2BPOLBP2RX7HTT
SCHEMBL7974249 0.88 ALDH1A1 (0.41) HPGDALDH1A1CYP11B1CYP11B2TSHR
SCHEMBL7988597 0.88 PARN (0.48) HPGDKMT2AP2RX7ALDH1A1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed